Around 90 scientific papers are being showcased in plenary, parallel, and poster sessions, covering topics like environmental pollution, toxicology, public health, risk assessment, remediation ...

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder strength in new dynamometry measurements Greater ...

Exposure to wildfire smoke can more than double the risk of respiratory failure or death for ALS patients, a study found.

CooperVision will present a range of scientific papers and posters in the British Contact Lens Association (BCLA) scientific stream at the 2026 ...

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

Oxford researchers have been given the chance to present their work to Parliament.

Catalyst Pharmaceuticals, Inc. ('Catalyst') (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living ...

H2Ocean proudly participated in the 4th International Conference on Cancer Health Disparities (ICCHD) & 9th Annual ...

For this month’s Female Filmmakers in Focus column, RogerEbert.com spoke to Glowicki over Zoom about chasing the high of making your friends laugh, the joys of DIY filmmaking, embracing mistakes, the ...

Labroots is thrilled to announce the 14th Annual Event in the Neuroscience Virtual Event Series in partnership with the NIH BRAIN Initiative, streaming live on March 4th, 2026. Join us as we dive into ...

Consuming more dietary protein may benefit people with various types of muscular dystrophy, according to a recent study.

ROCKVILLE, Md., March 4, 2026 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations on its RGX-202 investigational gene therapy for Duchenne muscular dystrophy at the 2026 ...